Cubist Systematic Strategies’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Cubist Systematic Strategies’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-12,775	Closed	-$683K	–	2061
2016 Q1	$683K	Buy	12,775 +2,980	+30%	+$220K	0.04%	630
2015 Q4	$1.11M	Sell	9,795 -5,329	-35%	-$587K	0.06%	434
2015 Q3	$1.78M	Buy	15,124 +12,842	+563%	+$1.68M	0.09%	307
2015 Q2	$177K	Buy	+2,282	New	+$150K	0.01%	1484
2015 Q1	–	Sell	-19,515	Closed	-$629K	–	2318
2014 Q4	$629K	Buy	19,515 +13,223	+210%	+$397K	0.03%	751
2014 Q3	$154K	Buy	+6,292	New	+$128K	0.01%	1457

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Cubist Systematic Strategies's ANAC Position: Q2 2016 in Review

Cubist Systematic Strategies sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 12,775 shares — an estimated $683K sold.

Cubist Systematic Strategies first reported a position in ANAC in Q3 2014 and held it in 6 quarters. The position peaked at $1.78M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Cubist Systematic Strategies reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Cubist Systematic Strategies sold 12,775 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $683K.
Cubist Systematic Strategies first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 6 quarters.
Cubist Systematic Strategies's ANACOR PHARMACEUTICALS INC COM position peaked at $1.78M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Cubist Systematic Strategies's 13F filing for Q2 2016, filed 15 Aug 2016.